Provides five-year cure rates approaching 99% for new cancers and 95% for recurrent cancers.
In Mohs surgery, the dermatologist performs the dual role of skin cancer surgeon and pathologist. The Mohs procedure involves the surgical removal of the visible portion of the skin cancer, along with a layer of the surrounding skin.
Clinical studies have demonstrated that Mohs surgery provides five-year cure rates approaching 99% for new cancers and 95% for recurrent cancers. Important advantages of the Mohs procedure are that it allows the greatest amount of surrounding healthy tissue to remain intact, potentially reducing the size of the final surgical defect and resulting scar; and that the methodical manner in which all lateral and deep tissue margins are examined enables the surgeon to detect and remove any “roots” of the skin cancer that may be present, which greatly reduces the likelihood of recurrence.
Quisque rutrum. Aenean imperdiet.. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium.